Detection and Prognostic Stratification of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Using an Artificial Intelligence-enabled ECG

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Left bundle branch block (LBBB) significantly increases the risk of left ventricular systolic dysfunction (LVSD) due to cardiac dyssynchrony. While artificial intelligence-enabled electrocardiography (AI-ECG) models show promise in detecting LVSD, their performance in LBBB patients remains underexplored. We hypothesized that a clinically validated AI-ECG model for detecting LVSD, can accurately detect LVSD and predict future clinical outcomes in LBBB patients. Methods In this retrospective multicenter study, 5,689 expert-validated LBBB ECGs from 2,813 patients collected between 2016 and 2024 were analyzed using AI-ECG model that had been previously developed and validated. LVSD was defined as ejection fraction (EF) ≤ 40%. Model performance was assessed using area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), sensitivity, and specificity. Patients were stratified into high- and low-risk groups based on a threshold achieving 90% sensitivity. Kaplan–Meier analysis compared clinical outcomes. Results Among 2,813 LBBB patients (mean age 70.7, male 43.7%), hypertension and a history of heart failure were common. The AiTiALVSD model showed strong diagnostic performance for LVSD (AUROC 0.930 [95% CI, 0.924–0.937]; AUPRC 0.913 [95% CI, 0.902–0.923]; sensitivity 0.979; specificity 0.473). Mean follow-up duration was 4.1 years. High-risk patients had significantly higher hazards for all-cause mortality (Hazard Ratio [HR] 2.29, 95% CI 1.89–2.77), implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy (CRT) implantation (HR 2.29, 95% CI 1.89–2.77), and cardiovascular hospitalization (HR 1.40, 95% CI 1.22–1.60) (all p values < 0.001). Conclusion AiTiALVSD effectively detects LVSD and stratifies long-term cardiovascular risk in LBBB patients, supporting its clinical utility for early detection and management.

Article activity feed